Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
Anne Hege Aamodt,
Einar A. Høgestøl,
Trine Haug Popperud,
Jan Cato Holter,
Anne Margarita Dyrhol-Riise,
Hanne Flinstad Harbo
Posted 09 Sep 2020
medRxiv DOI: 10.1101/2020.09.07.20189415
Posted 09 Sep 2020
Objective To test the hypotheses that serum concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) can serve as biomarkers for disease severity in COVID-19 patients. Methods Forty-seven inpatients with confirmed COVID-19 had blood samples drawn on admission for assessing serum biomarkers of CNS injury by Single molecule array (Simoa), NfL and GFAp. Concentrations of NfL and GFAp were analyzed in relation to symptoms, clinical signs, inflammatory biomarkers and clinical outcomes. We used multivariate linear models to test for differences in biomarker concentrations in the subgroups, accounting for confounding effects. Results In total, 21 % (n=10) of the patients were admitted to an intensive care unit, whereas the overall mortality rate was 13 % (n=6). Non-survivors had higher serum concentrations of NfL (p<0.001) than patients who were discharged alive both in adjusted analyses (p=2.6 x 10-7) and unadjusted analyses (p=0.001). The concentrations of NfL in non-survivors increased over repeated measurements whereas the concentrations in survivors were stable. Significantly higher concentrations of NfL were found in patients reporting fatigue, while reduced concentrations were found in patients experiencing cough, myalgia and joint pain. The GFAp concentration was also significantly higher in non-survivors than survivors (p=0.02). Conclusion Increased concentrations of NfL and GFAp in COVID-19 patients on admission may indicate increased mortality risk. Measurement of blood biomarkers for nervous system injury can be useful to detect and monitor CNS injury in COVID-19.
- Downloaded 283 times
- Download rankings, all-time:
- Site-wide: 88,848
- In infectious diseases: 3,536
- Year to date:
- Site-wide: 39,468
- Since beginning of last month:
- Site-wide: 29,299
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!